Selected article for: "bacterial protein and cell surface"

Author: Smith, Mary Ellen; Koser, Martin; Xiao, Sa; Siler, Catherine; McGettigan, James P.; Calkins, Catherine; Pomerantz, Roger J.; Dietzschold, Bernhard; Schnell, Matthias J.
Title: Rabies virus glycoprotein as a carrier for anthrax protective antigen
  • Cord-id: w219g6qs
  • Document date: 2006_9_30
  • ID: w219g6qs
    Snippet: Abstract Live viral vectors expressing foreign antigens have shown great promise as vaccines against viral diseases. However, safety concerns remain a major problem regarding the use of even highly attenuated viral vectors. Using the rabies virus (RV) envelope protein as a carrier molecule, we show here that inactivated RV particles can be utilized to present Bacillus anthracis protective antigen (PA) domain-4 in the viral membrane. In addition to the RV glycoprotein (G) transmembrane and cytopl
    Document: Abstract Live viral vectors expressing foreign antigens have shown great promise as vaccines against viral diseases. However, safety concerns remain a major problem regarding the use of even highly attenuated viral vectors. Using the rabies virus (RV) envelope protein as a carrier molecule, we show here that inactivated RV particles can be utilized to present Bacillus anthracis protective antigen (PA) domain-4 in the viral membrane. In addition to the RV glycoprotein (G) transmembrane and cytoplasmic domains, a portion of the RV G ectodomain was required to express the chimeric RV G anthrax PA on the cell surface. The novel antigen was also efficiently incorporated into RV virions. Mice immunized with the inactivated recombinant RV virions exhibited seroconversion against both RV G and anthrax PA, and a second inoculation greatly increased these responses. These data demonstrate that a viral envelope protein can carry a bacterial protein and that a viral carrier can display whole polypeptides compared to the limited epitope presentation of previous viral systems.

    Search related documents:
    Co phrase search for related documents
    • active immunization and live inactivated: 1, 2
    • active immunization and live vaccine: 1, 2, 3
    • active immunization passive and live inactivated: 1
    • live vaccine and low seroprevalence: 1
    • live vaccine and lymphocyte proliferation: 1, 2, 3